Literature DB >> 30366556

Acute Community-Acquired Bacterial Meningitis.

Ana Helena A Figueiredo1, Matthijs C Brouwer1, Diederik van de Beek2.   

Abstract

Community-acquired bacterial meningitis remains a disease with high impact. The epidemiology of this disease changed substantiality to large-scale introduction of conjugated vaccines. Streptococcus pneumoniae and Neisseria meningitidis are the main causative pathogens outside the neonatal age. Clinical presentation of patients with bacterial meningitis varies depending on age and underlying condition. A delay in diagnosis and antimicrobial therapy has been associated with increased risk of adverse clinical outcome. Empirical antibiotic treatment should be based on common bacterial species that cause the disease according to the patient's age group or clinical setting and on local antibiotic susceptibility patterns of the predominant pathogens.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial therapy; Community-acquired bacterial meningitis; Conjugate vaccines; Dexamethasone; Epidemiology; Lumbar puncture

Mesh:

Substances:

Year:  2018        PMID: 30366556     DOI: 10.1016/j.ncl.2018.06.007

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  1 in total

1.  Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis.

Authors:  Leonardo Silva de Araujo; Kevin Pessler; Kurt-Wolfram Sühs; Natalia Novoselova; Frank Klawonn; Maike Kuhn; Volkhard Kaever; Kirsten Müller-Vahl; Corinna Trebst; Thomas Skripuletz; Martin Stangel; Frank Pessler
Journal:  J Transl Med       Date:  2020-01-07       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.